We openly disclose our performance, progress and commitments to our key stakeholders both on financial and non-financial performance indicators. ALK’s approach to sustainability encompasses four key themes: `Access to allergy care´, `People´, `Environment´, and `Responsible business practices´.
Find out more in our annual sustainability report.
We have limited time for action and the private sector has a crucial role to play – every sector in every market must transform. By supporting international initiatives and engaging in partnerships, ALK contributes to promoting sustainable business practices globally.
For more than 10 years, we have been guided by the United Nations’ ten Global Compact principles and have been an active signatory since 2019.
In 2022, we signed a commitment letter to set science-based targets by 2023. This means we are committed to setting emission reduction targets in line with what the latest climate science deems necessary to limit the effects of global warming. Once the targets are set in 2023, we will have a clear path for how to reduce emissions and future-proof business growth. With this commitment, we join more than 4,000 businesses globally engaged in this initiative.
We build on decades of research & development and apply state-of-the-art pharmaceutical standards to deliver products and services to millions in need. However, millions more still lack access to modern medical care for their allergies and related asthma. Our ambition is to ensure access to allergy care by:
improving quality of life through better allergy treatment options and more efficient diagnosis earlier in life
supporting healthcare systems through training and education on allergy care
establishing partnerships to overcome geographic barriers to allergy care
Find our more in our Access to Medicines Policy.
Target setting is important for identifying material risks and opportunities, tracking progress, and gauging effectiveness. In 2020, ALK conducted a materiality assessment to identify areas with the highest impact on our business and stakeholders in order to outline targets in our four focus areas: `Access to allergy care´, `People´, `Environment´, and `Responsible business practices´. We have had good progress and met all our ambitions so far. In 2022 we committed to setting science-based targets and will be updating our targets in alignment with this framework for 2023 and beyond.
